394 related articles for article (PubMed ID: 23597092)
1. The role of benzodiazepines in breathlessness: a single site, open label pilot of sustained release morphine together with clonazepam.
Allcroft P; Margitanovic V; Greene A; Agar MR; Clark K; Abernethy AP; Currow DC
J Palliat Med; 2013 Jul; 16(7):741-4. PubMed ID: 23597092
[TBL] [Abstract][Full Text] [Related]
2. Effect of Sustained-Release Morphine for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease on Health Status: A Randomized Clinical Trial.
Verberkt CA; van den Beuken-van Everdingen MHJ; Schols JMGA; Hameleers N; Wouters EFM; Janssen DJA
JAMA Intern Med; 2020 Oct; 180(10):1306-1314. PubMed ID: 32804188
[TBL] [Abstract][Full Text] [Related]
3. Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study.
Currow DC; McDonald C; Oaten S; Kenny B; Allcroft P; Frith P; Briffa M; Johnson MJ; Abernethy AP
J Pain Symptom Manage; 2011 Sep; 42(3):388-99. PubMed ID: 21458217
[TBL] [Abstract][Full Text] [Related]
4. Management of refractory breathlessness with morphine in patients with chronic obstructive pulmonary disease.
Smallwood N; Le B; Currow D; Irving L; Philip J
Intern Med J; 2015 Sep; 45(9):898-904. PubMed ID: 26332621
[TBL] [Abstract][Full Text] [Related]
5. Blinded Patient Preference for Morphine Compared to Placebo in the Setting of Chronic Refractory Breathlessness--An Exploratory Study.
Ferreira DH; Silva JP; Quinn S; Abernethy AP; Johnson MJ; Oxberry SG; Currow DC
J Pain Symptom Manage; 2016 Feb; 51(2):247-54. PubMed ID: 26598037
[TBL] [Abstract][Full Text] [Related]
6. Effect of Regular, Low-Dose, Extended-release Morphine on Chronic Breathlessness in Chronic Obstructive Pulmonary Disease: The BEAMS Randomized Clinical Trial.
Ekström M; Ferreira D; Chang S; Louw S; Johnson MJ; Eckert DJ; Fazekas B; Clark KJ; Agar MR; Currow DC;
JAMA; 2022 Nov; 328(20):2022-2032. PubMed ID: 36413230
[TBL] [Abstract][Full Text] [Related]
7. A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion And Morphine Sulfate (BEAMS) study protocol.
Currow D; Watts GJ; Johnson M; McDonald CF; Miners JO; Somogyi AA; Denehy L; McCaffrey N; Eckert DJ; McCloud P; Louw S; Lam L; Greene A; Fazekas B; Clark KC; Fong K; Agar MR; Joshi R; Kilbreath S; Ferreira D; Ekström M;
BMJ Open; 2017 Jul; 7(7):e018100. PubMed ID: 28716797
[TBL] [Abstract][Full Text] [Related]
8. Repeat dose opioids may be effective for breathlessness in chronic heart failure if given for long enough.
Oxberry SG; Bland JM; Clark AL; Cleland JG; Johnson MJ
J Palliat Med; 2013 Mar; 16(3):250-5. PubMed ID: 23368980
[TBL] [Abstract][Full Text] [Related]
9. EffenDys-Fentanyl Buccal Tablet for the Relief of Episodic Breathlessness in Patients With Advanced Cancer: A Multicenter, Open-Label, Randomized, Morphine-Controlled, Crossover, Phase II Trial.
Simon ST; Kloke M; Alt-Epping B; Gärtner J; Hellmich M; Hein R; Piel M; Cornely OA; Nauck F; Voltz R
J Pain Symptom Manage; 2016 Nov; 52(5):617-625. PubMed ID: 27693898
[TBL] [Abstract][Full Text] [Related]
10. Patient-Controlled Therapy of Breathlessness in Palliative Care: A New Therapeutic Concept for Opioid Administration?
Schmitz A; Schulz C; Friebel U; Hohlfeld T; Bausewein C
J Pain Symptom Manage; 2016 Mar; 51(3):581-8. PubMed ID: 26578404
[TBL] [Abstract][Full Text] [Related]
11. Patients' and their caregivers' experiences with regular, low-dose, sustained-release morphine for chronic breathlessness associated with COPD: a qualitative study.
Ferreira D; Kochovska S; Honson A; Phillips J; Currow D
BMJ Open Respir Res; 2022 May; 9(1):. PubMed ID: 35606022
[TBL] [Abstract][Full Text] [Related]
12. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea.
Abernethy AP; Currow DC; Frith P; Fazekas BS; McHugh A; Bui C
BMJ; 2003 Sep; 327(7414):523-8. PubMed ID: 12958109
[TBL] [Abstract][Full Text] [Related]
13. Regular, sustained-release morphine for chronic breathlessness: a multicentre, double-blind, randomised, placebo-controlled trial.
Currow D; Louw S; McCloud P; Fazekas B; Plummer J; McDonald CF; Agar M; Clark K; McCaffrey N; Ekström MP;
Thorax; 2020 Jan; 75(1):50-56. PubMed ID: 31558624
[TBL] [Abstract][Full Text] [Related]
14. The longitudinal pattern of response when morphine is used to treat chronic refractory dyspnea.
Currow DC; Quinn S; Greene A; Bull J; Johnson MJ; Abernethy AP
J Palliat Med; 2013 Aug; 16(8):881-6. PubMed ID: 23746231
[TBL] [Abstract][Full Text] [Related]
15. Opioids in patients with COPD and refractory dyspnea: literature review and design of a multicenter double blind study of low dosed morphine and fentanyl (MoreFoRCOPD).
van Dijk M; Mooren KJM; van den Berg JK; van Beurden-Moeskops WJC; Heller-Baan R; de Hosson SM; Lam-Wong WY; Peters L; Pool K; Kerstjens HAM
BMC Pulm Med; 2021 Sep; 21(1):289. PubMed ID: 34507574
[TBL] [Abstract][Full Text] [Related]
16. Prescription of opioids for breathlessness in end-stage COPD: a national population-based study.
Ahmadi Z; Bernelid E; Currow DC; Ekström M
Int J Chron Obstruct Pulmon Dis; 2016; 11():2651-2657. PubMed ID: 27799763
[TBL] [Abstract][Full Text] [Related]
17. Testosterone Levels in People Taking Regular Low-Dose Sustained-Release Morphine for Persisting Breathlessness: An Exploratory Study.
Ferreira DH; Ekström M; Fazekas B; Currow DC
J Palliat Med; 2023 Mar; 26(3):402-405. PubMed ID: 36394475
[No Abstract] [Full Text] [Related]
18. Opioids for chronic refractory breathlessness: patient predictors of beneficial response.
Johnson MJ; Bland JM; Oxberry SG; Abernethy AP; Currow DC
Eur Respir J; 2013 Sep; 42(3):758-66. PubMed ID: 23258776
[TBL] [Abstract][Full Text] [Related]
19. Effects of low-dose morphine on perceived sleep quality in patients with refractory breathlessness: A hypothesis generating study.
Martins RT; Currow DC; Abernethy AP; Johnson MJ; Toson B; Eckert DJ
Respirology; 2016 Feb; 21(2):386-91. PubMed ID: 26560987
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial on the benefits and respiratory adverse effects of morphine for refractory dyspnea in patients with COPD: Protocol of the MORDYC study.
Verberkt CA; van den Beuken-van Everdingen MH; Franssen FM; Dirksen CD; Schols JM; Wouters EF; Janssen DJ
Contemp Clin Trials; 2016 Mar; 47():228-34. PubMed ID: 26825021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
